Karboplatin Hospira 10 mg/ml koncentrat za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

karboplatin hospira 10 mg/ml koncentrat za raztopino za infundiranje

hospira uk ltd. - karboplatin - koncentrat za raztopino za infundiranje - karboplatin 10 mg / 1 ml - karboplatin

Karboplatin Hospira 10 mg/ml koncentrat za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

karboplatin hospira 10 mg/ml koncentrat za raztopino za infundiranje

hospira uk ltd. - karboplatin - koncentrat za raztopino za infundiranje - karboplatin 10 mg / 1 ml - karboplatin

Karboplatin Hospira 10 mg/ml koncentrat za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

karboplatin hospira 10 mg/ml koncentrat za raztopino za infundiranje

hospira uk ltd. - karboplatin - koncentrat za raztopino za infundiranje - karboplatin 10 mg / 1 ml - karboplatin

Peroralna rehidracijska sol (Dolenjske lekarne) 22,29 g Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

peroralna rehidracijska sol (dolenjske lekarne) 22,29 g

peroralna rehidracijska sol - prašek za peroralno raztopino - peroralna rehidracijska sol 22,29 g / 1 vrečica - soli za peroralno rehidracijo

Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz) Evropska unija - slovenščina - EMA (European Medicines Agency)

corbilta (previously levodopa/carbidopa/entacapone sandoz)

orion corporation - levodopa, carbidopa, entacapone - parkinsonova bolezen - anti-parkinsonska zdravila - corbilta je indicirano za zdravljenje odraslih bolnikov s parkinsonovo boleznijo in konec odmerek motor nihanja ne ustalile na levodopo/dope decarboxylase (ddc) inhibitor zdravljenje.

Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva) Evropska unija - slovenščina - EMA (European Medicines Agency)

sevelamer carbonate winthrop (previously sevelamer carbonate zentiva)

sanofi b.v. - sevelamerijev karbonat - hyperphosphatemia; renal dialysis - vsi drugi terapevtski izdelki - sevelamer karbonat winthrop je označen za nadzor hyperphosphataemia pri odraslih bolnikih, ki prejemajo hemodializo ali peritonealno. sevelamer karbonat winthrop je tudi navedeno, za nadzor hyperphosphataemia pri odraslih bolnikih s kronično ledvično boleznijo, ki niso na dializi z fosforja v serumu > 1. 78 mmol / l. sevelamer karbonat winthrop je treba uporabljati v okviru več terapevtski pristop, ki bi vključeval kalcijev dodatek, 1,25-dihydroxy vitamin d3 (ali eno od njenih analogov nadzor razvoj ledvične bolezni kosti.

Zejula Evropska unija - slovenščina - EMA (European Medicines Agency)

zejula

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastična sredstva - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.

Inbrija Evropska unija - slovenščina - EMA (European Medicines Agency)

inbrija

acorda therapeutics ireland limited - levodopa - parkinsonova bolezen - anti-parkinsonska zdravila - inbrija je primerna za občasno zdravljenje epizodne motornih nihanja (off epizode) pri odraslih bolnikih s parkinsonovo boleznijo (pd), obdelan z levodopa/dope-decarboxylase zaviralec.

Jyseleca Evropska unija - slovenščina - EMA (European Medicines Agency)

jyseleca

gilead sciences ireland uc, galapagos nv - filgotinib maleate - artritis, revmatoidni - imunosupresivi - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Sibnayal Evropska unija - slovenščina - EMA (European Medicines Agency)

sibnayal

advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.